Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

RAY vs EPC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

RAY Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 6–4 Matrix Metrics)

RAY Overall Winner 6-Pillar Tally: RAY 3 – 2 EPC (1 Tie) Matrix Metrics: RAY 6 – 4 EPC

As of Nov 20, 2026, Raytech Holding Limited (RAY) is the stronger overall head-to-head candidate over Edgewell Personal Care Company (EPC) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). RAY carries a Unified Composite Score of 63.4/100 (BUY) at $2.80 (N/M Forward P/E, 12.7% operating margin), whereas EPC carries 55.0/100 (HOLD) at $28.47 (14.4x Forward P/E, 7.3% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About RAY vs EPC
RAY NASDAQ Head-to-Head Winner
Raytech Holding Limited Ordinary Shares
Household Appliances
$2.80
+8.74% 1D
Market Cap $15.1M
TTM Revenue $46M
Forward P/E N/M
Beta / 30D Vol -0.24β · 50% Vol
Unified Composite Score
63.4 / 100 BUY
Tech 64.0 Fund 57.0 Flow 50.0 Mom 35.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 51.3 · SMA20: $2.75 · SMA50: $2.84
EPC NYSE
Edgewell Personal Care Company
Perfumes, Cosmetics & Other Toilet Preparations
$28.47
+3.34% 1D
Market Cap $1.3B
TTM Revenue $2.00B
Forward P/E 14.4x
Beta / 30D Vol 0.16β · 48% Vol
Unified Composite Score
55.0 / 100 HOLD
Tech 62.0 Fund 54.0 Flow 50.0 Mom 46.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 51.3 · SMA20: $28.42 · SMA50: $27.88

6-Pillar Scorecard Institutional Category Breakdown (RAY 3 – 2 EPC)

Columns: Metric · RAY · EPC
1. Valuation Multiples EPC
Forward P/E N/M 14.4x
Trailing P/E 2.8x 21.5x
PEG Ratio N/M 2.87x
EV / Revenue 0.3x 0.6x
2. Growth & Scale RAY
Revenue Growth (YoY) +196.0% +3.0%
Earnings Growth (YoY) +33.5% -53.4%
TTM Revenue (USD) $46M $2.00B
Market Cap $15.1M $1.3B
3. Profitability & Quality RAY
Gross Margin 27.8% 43.0%
Operating Margin 12.7% 7.3%
Net Profit Margin 11.7% -2.6%
Return on Equity (ROE) 16.2% -0.1%
4. Balance Sheet & Cash Flow RAY
Cash Generation (TTM) $5.9M EBITDA $218M EBITDA
Cash Flow Margin 12.8% EBITDA Mgn 10.9% EBITDA Mgn
Net Cash / Leverage $6.06 Book/Sh · 16.2% ROE $31.94 Book/Sh · -0.1% ROE
Dividend Yield None (0.00%) 2.12%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 40.9% (5th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat EPC
OpEx & R&D Intensity 15.1% of Rev ($7.0M) 35.7% of Rev ($713M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Household & Personal Products Operator Household & Personal Products Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: RAY (6) vs EPC (4)
Institutional Metric RAY EPC Criterion Row Edge
Market Capitalization
Scale
$15.1M $1.3B Larger Scale EPC
Trailing P/E Ratio
Valuation
2.8x 21.5x Lower Multiple RAY
Forward P/E Ratio
Valuation
N/M 14.4x Lower Multiple EPC
Revenue Growth (YoY)
Growth
+196.0% +3.0% Higher Growth RAY
Operating Margin (TTM)
Profitability
12.7% 7.3% Higher Margin RAY
Net Profit Margin
Profitability
11.7% -2.6% Higher Margin RAY
Return on Equity (ROE)
Capital Efficiency
16.2% -0.1% Higher ROE RAY
52-Week Range Position
Momentum
45% ($0–$6) 87% ($16–$30) Stronger Trend EPC
Beta / 30D Volatility
Risk Regime
-0.24β · 50% Vol 0.16β · 48% Vol Lower Realized Risk EPC
Unified Institutional Score
Composite Signal
63.4 / 100 (BUY) 55.0 / 100 (HOLD) Higher Composite RAY
Trailing 12M Revenue (USD)
Operating Scale
$46M $2.00B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
27.8% 43.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.3x EV/Rev 2.87x PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$5.9M EBITDA ($6.06 Book/Sh · 16.2% ROE) $218M EBITDA ($31.94 Book/Sh · -0.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon RAY +0.11 pp
RAY: -4.44% · EPC: -4.55%
3M Horizon EPC +51.99 pp
RAY: -14.89% · EPC: +37.1%
6M Horizon EPC +69.19 pp
RAY: -40.8% · EPC: +28.39%
1Y Horizon EPC +4.07 pp
RAY: +51.35% · EPC: +55.42%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RAY vs EPC. Trailing 12-month operating profitability (RAY 12.7% vs EPC 7.3%) and valuation multiples (RAY N/M vs EPC 14.4x Forward P/E) are benchmarked directly in Pillar 4 below.

RAY ADR TTM Benchmark FX-Normalized USD
TTM Revenue$46M
Gross Margin27.8%
Op. Margin12.7%
ROE / Fwd P/E16.2% · N/M
EPC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.00B
Gross Margin43.0%
Op. Margin7.3%
ROE / Fwd P/E-0.1% · 14.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
RAY UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RAY Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
EPC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 40.9%
IV Percentile 5th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact EPC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
RAY Moat Profile Cyclical / Execution-Driven Positioning
Household & Personal Products Operator
Competes within the Household & Personal Products value chain with $15.1M market capitalization and 12.7% operating margin.
OpEx & R&D Reinvestment 15.1% of Rev ($7.0M)
90D Engineering Disclosures 0 Published
EPC Moat Profile Cyclical / Execution-Driven Positioning
Household & Personal Products Operator
Competes within the Household & Personal Products value chain with $1.3B market capitalization and 7.3% operating margin.
OpEx & R&D Reinvestment 35.7% of Rev ($713M)
90D Engineering Disclosures 0 Published

Investor FAQ RAY vs EPC Key Questions & Quantitative Answers

As of Nov 20, 2026, Raytech Holding Limited (RAY) is the stronger overall head-to-head candidate over Edgewell Personal Care Company (EPC) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). RAY carries a Unified Composite Score of 63.4/100 (BUY) at $2.80 (N/M Forward P/E, 12.7% operating margin), whereas EPC carries 55.0/100 (HOLD) at $28.47 (14.4x Forward P/E, 7.3% operating margin). Technically, RAY sits in a Neutral phase (RSI 51.3, UNCLASSIFIED options structure) and EPC sits in a Neutral phase (RSI 51.3, UNCLASSIFIED options structure).

RAY leads the Growth & Scale pillar: RAY posts +196.0% YoY revenue growth and +33.5% YoY earnings growth on $46M TTM revenue (27.8% gross margin, 12.7% operating margin), compared with EPC at +3.0% YoY revenue growth and -53.4% YoY earnings growth on $2.00B TTM revenue (43.0% gross margin, 7.3% operating margin). On trailing 12-month operating scale, RAY generates $46M in USD-normalized revenue versus $2.00B for EPC. In operating R&D and SG&A reinvestment, RAY deploys 15.1% of Rev ($7.0M) (0 90-day corporate R&D disclosures) versus 35.7% of Rev ($713M) (0 disclosures) for EPC.

EPC screens cheaper on headline valuation multiples. RAY trades at N/M Forward P/E, 2.8x Trailing P/E, N/M PEG, and 0.3x EV/Revenue (12.8% EBITDA margin), whereas EPC trades at 14.4x Forward P/E, 21.5x Trailing P/E, 2.87x PEG, and 0.6x EV/Revenue (10.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RAY (16.2% ROE) versus EPC (-0.1% ROE) capital efficiency.

In options market volatility and institutional positioning, RAY carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.24β · 50% Vol realized risk). By comparison, EPC carries 40.9% implied volatility (5th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.16β · 48% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.